The drug response of a normal and a multi-resistant strain of P. falciparum to sulphalene.
D002738:Chloroquine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D010963:Plasmodium falciparum / Q000187:drug effects*; D011739:Pyrimethamine / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D011803:Quinine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use*
D005493:Folic Acid Antagonists; D011743:Pyrimidines; D013449:Sulfonamides; D002738:Chloroquine; D011803:Quinine; D011739:Pyrimethamine